Acute Coronary Syndrome Treatment Cost Estimation in Selected Health Care Units in Poland – Pilot Survey Results
Background: The circulatory system diseases are one of biggest health problems which still pose a fundamental cause of mortality in developed countries. Among those illnesses important place takes myocardial ischemia. Aim: The main purpose of this article is to evaluate hospitalization costs of a...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Faculty of Economics and Business in Osijek
2010-07-01
|
| Series: | Ekonomski Vjesnik |
| Subjects: | |
| Online Access: | http://hrcak.srce.hr/file/89163 |
| _version_ | 1797329502664130560 |
|---|---|
| author | Agnieszka Maciag |
| author_facet | Agnieszka Maciag |
| author_sort | Agnieszka Maciag |
| collection | DOAJ |
| description | Background: The circulatory system diseases are one of biggest health problems which still pose a fundamental
cause of mortality in developed countries. Among those illnesses important place takes myocardial
ischemia. Aim: The main purpose of this article is to evaluate hospitalization costs of a patient with acute
coronary syndrome in health care units conducting diagnostic and surgery (coronarography and PTCA) as
well as in health centres, where patients are treated exclusively pharmacologically. Methods: There has been
prepared and used author's individual questionnaire enabling estimation of both fixed and variable treatment
costs per patient. In economic analysis there have been used micro-costing principle, defining every
element of used supplies and calculating unit cost. Results: The analysis has shown that fixed costs of one
hospitalized patient in a clinic equipped in hemodynamics laboratory are only 33% of all costs. In hospitals
which did not carry out surgeries, variable costs (e.g. medicines) were respectively lower, whereas fixed
costs were up to 72% of total treatment costs. A great impact on level of costs had two risk factors: smoking
tobacco and hypercholesterolemia. Conclusions: Increasing number of carried out angioplasty, raises total
treatment costs of acute coronary syndrome. Over half of all hospitalization costs of one patient with myocardial
ischemia in hospitals not equipped in hemodynamics laboratories determines for fixed costs. |
| first_indexed | 2024-03-08T07:06:43Z |
| format | Article |
| id | doaj.art-682c0beb1d1d4fcbbc1f30bf03a3509f |
| institution | Directory Open Access Journal |
| issn | 0353-359X 1847-2206 |
| language | English |
| last_indexed | 2024-03-08T07:06:43Z |
| publishDate | 2010-07-01 |
| publisher | Faculty of Economics and Business in Osijek |
| record_format | Article |
| series | Ekonomski Vjesnik |
| spelling | doaj.art-682c0beb1d1d4fcbbc1f30bf03a3509f2024-02-03T04:34:06ZengFaculty of Economics and Business in OsijekEkonomski Vjesnik0353-359X1847-22062010-07-01XXIII1248259Acute Coronary Syndrome Treatment Cost Estimation in Selected Health Care Units in Poland – Pilot Survey ResultsAgnieszka MaciagBackground: The circulatory system diseases are one of biggest health problems which still pose a fundamental cause of mortality in developed countries. Among those illnesses important place takes myocardial ischemia. Aim: The main purpose of this article is to evaluate hospitalization costs of a patient with acute coronary syndrome in health care units conducting diagnostic and surgery (coronarography and PTCA) as well as in health centres, where patients are treated exclusively pharmacologically. Methods: There has been prepared and used author's individual questionnaire enabling estimation of both fixed and variable treatment costs per patient. In economic analysis there have been used micro-costing principle, defining every element of used supplies and calculating unit cost. Results: The analysis has shown that fixed costs of one hospitalized patient in a clinic equipped in hemodynamics laboratory are only 33% of all costs. In hospitals which did not carry out surgeries, variable costs (e.g. medicines) were respectively lower, whereas fixed costs were up to 72% of total treatment costs. A great impact on level of costs had two risk factors: smoking tobacco and hypercholesterolemia. Conclusions: Increasing number of carried out angioplasty, raises total treatment costs of acute coronary syndrome. Over half of all hospitalization costs of one patient with myocardial ischemia in hospitals not equipped in hemodynamics laboratories determines for fixed costs.http://hrcak.srce.hr/file/89163acute coronary syndromecoronary vessel angioplastytreatment costsstent |
| spellingShingle | Agnieszka Maciag Acute Coronary Syndrome Treatment Cost Estimation in Selected Health Care Units in Poland – Pilot Survey Results Ekonomski Vjesnik acute coronary syndrome coronary vessel angioplasty treatment costs stent |
| title | Acute Coronary Syndrome Treatment Cost Estimation in Selected Health Care Units in Poland – Pilot Survey Results |
| title_full | Acute Coronary Syndrome Treatment Cost Estimation in Selected Health Care Units in Poland – Pilot Survey Results |
| title_fullStr | Acute Coronary Syndrome Treatment Cost Estimation in Selected Health Care Units in Poland – Pilot Survey Results |
| title_full_unstemmed | Acute Coronary Syndrome Treatment Cost Estimation in Selected Health Care Units in Poland – Pilot Survey Results |
| title_short | Acute Coronary Syndrome Treatment Cost Estimation in Selected Health Care Units in Poland – Pilot Survey Results |
| title_sort | acute coronary syndrome treatment cost estimation in selected health care units in poland pilot survey results |
| topic | acute coronary syndrome coronary vessel angioplasty treatment costs stent |
| url | http://hrcak.srce.hr/file/89163 |
| work_keys_str_mv | AT agnieszkamaciag acutecoronarysyndrometreatmentcostestimationinselectedhealthcareunitsinpolandpilotsurveyresults |